Comparative analysis of pharmacophore screening tools

Journal of Chemical Information and Modeling

Volumn 52, Issue 6, 2012, Pages 1607-1620

  Sanders, Marijn P A ^a,e   Barbosa, Arménio J M ^b   Zarzycka, Barbara ^c   Nicolaes, Gerry A F ^c   Klomp, Jan P G ^d   De Vlieg, Jacob ^a,e   Del Rio, Alberto ^b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Lead Pharma Medicine   (Netherlands)

^e NETHERLANDS ESCIENCE CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; HYPERSONIC AERODYNAMICS;

BIOLOGICAL TARGETS; COMPARATIVE ANALYSIS; COMPOUND LIBRARIES; COMPUTER AIDED DRUG DESIGN; FURTHER DEVELOPMENT; MEDICINAL CHEMISTRY; SCREENING ALGORITHMS; SEARCH ALGORITHMS;

PHARMACODYNAMICS;

ALGORITHM; ARTICLE; CHEMISTRY; COMPUTER AIDED DESIGN; DRUG DESIGN; DRUG SCREENING;

ALGORITHMS; CHEMISTRY, PHARMACEUTICAL; COMPUTER-AIDED DESIGN; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL;

EID: 84862848179     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci2005274     Document Type: Article

References (61)

1. Molecular Design: Concepts and Applications; Schneider, G., Baringhaus, K., and Kubinyi, H., Eds.; Wiley-VCH: Weinheim, 2008.
2. Chemoinformatics Approaches to Virtual Screening; Varnek, A. and Tropsha, A., Eds.; RSC Publishing: Cambridge, 2008.
3. Chemoinformatics; Gasteiger, J. and Engel, T., Eds.; Wiley-VCH: Weinheim, 2003.
4. Caporuscio, F.; Rastelli, G.; Imbriano, C.; Del Rio, A. Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking J. Med. Chem. 2011, 54 (12) 4006-4017
5. Kolb, P.; Ferreira, R. S.; Irwin, J. J.; Shoichet, B. K. Docking and chemoinformatic screens for new ligands and targets Curr. Opin. Chem. Biol. 2009, 20 (4) 429-436
6. Villoutreix, B. O.; Renault, N.; Lagorce, D.; Sperandio, O.; Montes, M.; Miteva, M. A. Free resources to assist structure-based virtual ligand screening experiments Curr. Protein Pept. Sci. 2007, 8 (4) 381-411
7. Ballester, P. J.; Westwood, I.; Laurieri, N.; Sim, E.; Richards, W. G. Prospective virtual screening with Ultrafast Shape Recognition: The identification of novel inhibitors of arylamine N-acetyltransferases J. R. Soc., Interface 2010, 7 (43) 335-342
8. Schneider, G. Virtual screening: An endless staircase? Nat. Rev. Drug Discovery 2010, 9 (4) 273-276
9. Leach, A. R.; Gillet, V. J.; Lewis, R. A.; Taylor, R. Three-dimensional pharmacophore methods in drug discovery J. Med. Chem. 2010, 53 (2) 539-558
10. Langer, T. Pharmacophores in drug research Mol. Inf. 2010, 29 (6-7) 470-475
11. Caporuscio, F.; Tafi, A. Pharmacophore modelling: A forty year old approach and its modern synergies Curr. Med. Chem. 2011, 18 (17) 2543-2553
12. Sun, H. Pharmacophore-based virtual screening Curr. Med. Chem. 2008, 15 (10) 1018-1024
13. Del Rio, A.; Barbosa, A.; Caporuscio, F., Use of large multiconformational databases with structure-based pharmacophore models for fast screening of commercial compound collections. J. Cheminf. [online] 2011, 3 (Suppl 1), P27, http://www.jcheminf.com/content/3/S1/P27 (accessed February 2, 2012).
14. Del Rio, A.; Barbosa, A. J.; Caporuscio, F.; Mangiatordi, G. F. CoCoCo:A free suite of multiconformational chemical databases for high-throughput virtual screening purposes Mol. BioSyst. 2010, 6 (11) 2122-2128
15. Irwin, J. J.; Shoichet, B. K. ZINC: A free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 2005, 45 (1) 177-182
16. Masciocchi, J.; Frau, G.; Fanton, M.; Sturlese, M.; Floris, M.; Pireddu, L.; Palla, P.; Cedrati, F.; Rodriguez-Tome, P.; Moro, S. MMsINC: A large-scale chemoinformatics database Nucleic Acids Res. 2009, 37 (Database issue) D284-290
17. Barbosa, A. J.; Del Rio, A. Freely accessible databases of commercial compounds for high-throughput virtual screenings Curr. Top. Med. Chem. 2012, 12 (8) 866-877
18. Oellien, F.; Cramer, J.; Beyer, C.; Ihlenfeldt, W. D.; Selzer, P. M. The impact of tautomer forms on pharmacophore-based virtual screening J. Chem. Inf. Model. 2006, 46 (6) 2342-2354
19. Kolb, P.; Irwin, J. J. Docking screens: Right for the right reasons? Curr. Top. Med. Chem. 2009, 9 (9) 755-770
20. Chen, Z.; Li, H. L.; Zhang, Q. J.; Bao, X. G.; Yu, K. Q.; Luo, X. M.; Zhu, W. L.; Jiang, H. L. Pharmacophore-based virtual screening versus docking-based virtual screening: A benchmark comparison against eight targets Acta Pharmacol. Sin. 2009, 30 (12) 1694-1708
21. Kirchmair, J.; Markt, P.; Distinto, S.; Wolber, G.; Langer, T. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection-What can we learn from earlier mistakes? J. Comput.-Aided Mol. Des. 2008, 22 (3-4) 213-228
22. ten Brink, T.; Exner, T. E. Influence of protonation, tautomeric, and stereoisomeric states on protein-ligand docking results J. Chem. Inf. Model. 2009, 49 (6) 1535-1546
23. Patel, Y.; Gillet, V. J.; Bravi, G.; Leach, A. R. A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP J. Comput.-Aided Mol. Des. 2002, 16 (8-9) 653-681
24. Peach, M. L.; Nicklaus, M. C., Combining docking with pharmacophore filtering for improved virtual screening. J. Cheminf. [online] 2009, 1 (1), 6, http://www.jcheminf.com/content/1/1/6 (accessed February 2, 2012).
25. Brown, S. P.; Muchmore, S. W. Large-scale application of high-throughput molecular mechanics with Poisson-Boltzmann surface area for routine physics-based scoring of protein-ligand complexes J. Med. Chem. 2009, 52 (10) 3159-3165
26. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank Nucleic Acids Res. 2000, 28 (1) 235-242
27. Morgan, D. O. Cyclin-dependent kinases: Engines, clocks, and microprocessors Annu. Rev. Cell Dev. Biol. 1997, 13, 261-291
28. Sanchez, Y.; Wong, C.; Thoma, R. S.; Richman, R.; Wu, Z.; Piwnica-Worms, H.; Elledge, S. J. Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25 Science 1997, 277 (5331) 1497-1501
29. Elchebly, M.; Payette, P.; Michaliszyn, E.; Cromlish, W.; Collins, S.; Loy, A. L.; Normandin, D.; Cheng, A.; Himms-Hagen, J.; Chan, C. C.; Ramachandran, C.; Gresser, M. J.; Tremblay, M. L.; Kennedy, B. P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene Science 1999, 283 (5407) 1544-1548
30. Andreasen, P. A.; Kjoller, L.; Christensen, L.; Duffy, M. J. The urokinase-type plasminogen activator system in cancer metastasis: A review Int. J. Cancer 1997, 72 (1) 1-22
31. Apweiler, R.; Bairoch, A.; Wu, C. H.; Barker, W. C.; Boeckmann, B.; Ferro, S.; Gasteiger, E.; Huang, H.; Lopez, R.; Magrane, M.; Martin, M. J.; Natale, D. A.; O'Donovan, C.; Redaschi, N.; Yeh, L. S. UniProt: The Universal Protein knowledgebase Nucleic Acids Res. 2004, 32 (Database issue) D115-119
32. Sybyl X; Tripos:: St. Louis, MO.
33. Epik, version 2.1107; Schrödinger, LLC: Portland, OR, 2011.
34. Renner, S.; Schneider, G. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening J. Med. Chem. 2004, 47 (19) 4653-4664
35. CoCoCo Database. http://www.cococo-database.it (accessed date February 2, 2012)
36. Wild, D. J.; Blankley, C. J. Comparison of 2D fingerprint types and hierarchy level selection methods for structural grouping using Ward's clustering J. Chem. Inf. Comput. Sci. 2000, 40 (1) 155-162
37. ChEMBL. https://www.ebi.ac.uk/chembldb/ (accessed date February 2, 2012)
38. Warr, W. ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI) J. Comput.-Aided Mol. Des. 2009, 23 (4) 195-198
39. Rohrer, S. G.; Baumann, K. Maximum unbiased validation (MUV) data sets for virtual screening based on PubChem bioactivity data J. Chem. Inf. Model. 2009, 49 (2) 169-184
40. Maximum Unbiased Validation (MUV), Datasets for Virtual Screening. http://www.pharmchem.tu-bs.de/lehre/baumann/MUV.html (accessed date February 2, 2012)
41. Watts, K. S.; Dalal, P.; Murphy, R. B.; Sherman, W.; Friesner, R. A.; Shelley, J. C. ConfGen: A conformational search method for efficient generation of bioactive conformers J. Chem. Inf. Model. 2010, 50 (4) 534-546
42. Taminau, J.; Thijs, G.; De Winter, H. Pharao: pharmacophore alignment and optimization J. Mol. Graphics Modell. 2008, 27 (2) 161-169
43. Landrum, G. RDkit. http://rdkit.org (accessed date February 2, 2012).
44. Accelrys Inc. http://accelrys.com (accessed date Feb 2, 2012).
45. Koes, D. R.; Camacho, C. J. Pharmer: Efficient and exact pharmacophore search J. Chem. Inf. Model. 2011, 51 (6) 1307-1314
46. Sanders, M. P.; Verhoeven, S.; de Graaf, C.; Roumen, L.; Vroling, B.; Nabuurs, S. B.; de Vlieg, J.; Klomp, J. P. Snooker: A structure-based pharmacophore generation tool applied to class A GPCRs J. Chem. Inf. Model. 2011, 51 (9) 2277-2292
47. Chemical Computing Group. http://www.chemcomp.com (accessed date February 2, 2012).
48. Wolber, G.; Langer, T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters J. Chem. Inf. Model. 2004, 45 (1) 160-169
49. Phase, version 3.3; Schrödinger, LLC: Portland, OR, USA, 2011.
50. Jain, A. N.; Nicholls, A. Recommendations for evaluation of computational methods J. Comput.-Aided Mol. Des. 2008, 22 (3-4) 133-139
51. Agrafiotis, D. K.; Gibbs, A. C.; Zhu, F.; Izrailev, S.; Martin, E. Conformational sampling of bioactive molecules: A comparative study J. Chem. Inf. Model. 2007, 47 (3) 1067-1086
52. Griewel, A.; Kayser, O.; Schlosser, J.; Rarey, M. Conformational sampling for large-scale virtual screening: accuracy versus ensemble size J. Chem. Inf. Model. 2009, 49 (10) 2303-2311
53. Zou, J.; Xie, H. Z.; Yang, S. Y.; Chen, J. J.; Ren, J. X.; Wei, Y. Q. Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2 J. Mol. Graphics Modell. 2008, 27 (4) 430-438
54. Chen, X. M.; Lu, T.; Lu, S.; Li, H. F.; Yuan, H. L.; Ran, T.; Liu, H. C.; Chen, Y. D. Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors J. Mol. Model. 2010, 16 (7) 1195-1204
55. Zhang, S.; Zhang, Z. Y. PTP1B as a drug target: Recent developments in PTP1B inhibitor discovery Drug Discovery Today 2007, 12 (9-10) 373-381
56. Shui, L.; Bharatham, N.; Bharatham, K.; Lee, K. W., Urokinase inhibitor design based on pharmacophore model derived from diverse classes of inhibitors. Interdiscip. Bio Cent. [online] 2009, http://www.ibc7.org/article/e-archive-v. php?sid=67 (accessed February 2, 2012)
57. Wolber, G.; Seidel, T.; Bendix, F.; Langer, T. Molecule-pharmacophore superpositioning and pattern matching in computational drug design Drug Discovery Today 2008, 13 (1-2) 23-29
58. Spitzer, G. M.; Heiss, M.; Mangold, M.; Markt, P.; Kirchmair, J.; Wolber, G.; Liedl, K. R. One concept, three implementations of 3D pharmacophore-based virtual screening: Distinct coverage of chemical search space J. Chem. Inf. Model. 2010, 50 (7) 1241-1247
59. Agrafiotis, D. K. Stochastic proximity embedding J. Comput. Chem. 2003, 24 (10) 1215-1221
60. Agrafiotis, D. K.; Xu, H. A self-organizing principle for learning nonlinear manifolds Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (25) 15869-15872
61. BCI Fingerprints. Barnard Chemical Information Ltd.. http://www.bci1. demon.co.uk/ (accessed date February 2, 2012).